Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial

BACKGROUND: COVID-19 vaccines that offer broad-spectrum protection are needed. We aimed to evaluate the safety and immunogenicity of multivalent vaccines, SCTV01E and SCTV01C, and compare them with an inactivated vaccine. METHODS: In the phase 3 trial (ClinicalTrials.gov: NCT05323461), adult partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannawi, Suad, Yan, Lixin, Saifeldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Zhang, Miaomiao, Gao, Cuige, Chen, Yuanxin, Gai, Wenlin, Xie, Liangzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507195/
https://www.ncbi.nlm.nih.gov/pubmed/37731938
http://dx.doi.org/10.1016/j.eclinm.2023.102195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507195/
https://www.ncbi.nlm.nih.gov/pubmed/37731938
http://dx.doi.org/10.1016/j.eclinm.2023.102195

Ejemplares similares